Clinical Research Services Market, 2012-2023

January 2018 | 210 pages | ID: C3B817864F7EN
Precision Business Insights (PBI)

Abstracts

Clinical research services market: Clinical research is a branch of healthcare that studies whether a medical strategy, medicine, medical device, diagnostics and treatment regimes is safe and effective for human use. Clinical research may contribute to treatment, prevention, diagnosis or relieving certain symptoms of disease or condition. Clinical research is carried out with a pool of patients or people under study condition. Clinical research is a broad term which includes many research studies such as treatment, prevention, diagnostic, screening, genetic, epidemiological and clinical trial studies.

Global Market Outline: Clinical Research Services Market

Global clinical research services market is driven by increased burden of chronic diseases such as HIV, cancer and cardio vascular diseases, which requires huge investments. Pharmaceutical and biotechnological companies outsource their clinical research activities to clinical research service organizations to reduce the cost and regulatory burdens. In addition, enormous growth in biopharmaceutical segment, discovery of the new drugs through innovation and increase in clinical trials are expected to boost the clinical research services market over the forecast period. However, increase in clinical research costs, stringent regulatory procedures and ethical issues are hindering the clinical research services market.

Clinical research services market has been segmented based on type of service, therapeutic area, end user, and region

Based on type of service, clinical research services market is segmented into

• Treatment Research
• Prevention Research
• Diagnostic Research
• Screening Research
• Quality of LifeResearch
• Genetic studies
• Epidemiological studies
• Clinical Trials
• Others

Base on disease area, clinical research services market is segmented into

• Oncology
• Central Nervous System Disorders
• Cardio Vascular Disorders
• Diabetes
• Infectious Diseases
• Others

Based on end-user, clinical research services market is segmented into

• Pharmaceutical Companies
• Biotechnological Companies
• Research Organizations
• Others

Clinical research services market is at steady stage of growth. The market is expected to grow at a significant rate during the forecast period. Market players are expanding their markets by offering various services and collaborations. For instance in June 2017, PAREXEL International Corporation, a leading global biopharmaceutical services organization, collaborated with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials. Moreover, In order to maintain market position, companies adopting mergers and acquisitions as their key strategies. For instance, in May, 2017 and inVentiv Health, Inc. and INC Research Holdings, Inc., announced a definitive merger agreement to create a leading biopharmaceutical solutions organization. Similarly, in April 2016, Charles River Laboratories acquired WIL Research to enhance its global footprint, scientific capabilities, and access to growing market segments.

Geographically clinical research services market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America clinical research services market expected to be leading clinical research services market owing to factors such as favourable regulations, developed infrastructure, increase in research and development activities and availability of pool of patients. Europe clinical research services market expected to grow at significant rate owing to increase in R&D activities by pharma and biotechnological companies and favourable regulatory environment and government policies. Asia Pacific region clinical research services market is expected to be fastest growing owing to developing regulatory policies, low cost of the research and availability of a large number of patients.

Some of the players in Clinical Research Services market are Laboratory Corporation Of America Holdings (U.S.), Quintiles Transnational Holdings Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Wuxi AppTec (Cayman) Inc. (China), Pharmaceutical Product Development, LLC (U.S.), INC Research Holdings Inc. (U.S.), and Charles River Laboratories International Inc. (U.S.), to name a few.

In October 2015, WuXi PharmaTech (Cayman) Inc. and Gilead Sciences, Inc., strategically partnered in conducting analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products.

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL CLINICAL RESEARCH SERVICES MARKET INTRODUCTION

2.1. Global Clinical Research Services Market – Taxonomy
2.2. Global Clinical Research Services Market –Definitions
  2.2.1. Service Type
  2.2.2. Disease Area

3. GLOBAL CLINICAL RESEARCH SERVICES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Clinical Research Services Market Dynamic Factors - Impact Analysis

4. GLOBAL CLINICAL RESEARCH SERVICES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis

5. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY SERVICE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

5.1. Treatment Research
  5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Prevention Research
  5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Diagnostic Research
  5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Screening Research
  5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Quality of Life Research
  5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Genetic Studies
  5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis
5.7. Epidemiological Studies
  5.7.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis
5.8. Clinical Trials
  5.8.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.8.3. Market Opportunity Analysis
5.9. Others
  5.9.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.9.3. Market Opportunity Analysis

6. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY DISEASE AREA, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

6.1. Oncology
  6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. CNS Disorders
  6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Cardio Vascular Disorders
  6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Diabetes
  6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Infectious Diseases
  6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis
6.6. Others
  6.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.6.3. Market Opportunity Analysis

7. GLOBAL CLINICAL RESEARCH SERVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

7.1. North America
  7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Europe
  7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
  7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Latin America
  7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
  7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Global Clinical Research Services Market - Opportunity Analysis Index, By Service Type, By Disease Area, and Region, 2017 – 2023

8. NORTH AMERICA CLINICAL RESEARCH SERVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

8.1. Service Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.1.1. Treatment Research
  8.1.2. Prevention Research
  8.1.3. Diagnostic Research
  8.1.4. Screening Research
  8.1.5. Quality of LifeResearch
  8.1.6. Genetic studies
  8.1.7. Epidemiological studies
  8.1.8. Clinical Trials
  8.1.9. Others
8.2. Disease Area Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.2.1. Oncology
  8.2.2. Central Nervous System Disorders
  8.2.3. Cardio Vascular Disorders
  8.2.4. Diabetes
  8.2.5. Infectious Diseases
  8.2.6. Others
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  8.3.1. U.S.
  8.3.2. Canada
8.4. North America Clinical Research Services Market - Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2017 – 2023
8.5. North America Clinical Research Services Market Dynamics – Trends

9. EUROPE CLINICAL RESEARCH SERVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

9.1. Service Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Treatment Research
  9.1.2. Prevention Research
  9.1.3. Diagnostic Research
  9.1.4. Screening Research
  9.1.5. Quality of LifeResearch
  9.1.6. Genetic studies
  9.1.7. Epidemiological studies
  9.1.8. Clinical Trials
  9.1.9. Others
9.2. Disease Area Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.2.1. Oncology
  9.2.2. Central Nervous System Disorders
  9.2.3. Cardio Vascular Disorders
  9.2.4. Diabetes
  9.2.5. Infectious Diseases
  9.2.6. Others
9.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Germany
  9.3.2. UK
  9.3.3. France
  9.3.4. Spain
  9.3.5. Italy
  9.3.6. Russia
  9.3.7. Poland
  9.3.8. Rest of Europe
9.4. Europe Clinical Research Services Market - Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2017 – 2023
9.5. Europe Clinical Research Services Market Dynamics – Trends

10. ASIA-PACIFIC CLINICAL RESEARCH SERVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

10.1. Service Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Treatment Research
  10.1.2. Prevention Research
  10.1.3. Diagnostic Research
  10.1.4. Screening Research
  10.1.5. Quality of LifeResearch
  10.1.6. Genetic studies
  10.1.7. Epidemiological studies
  10.1.8. Clinical Trials
  10.1.9. Others
10.2. Disease Area Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.2.1. Oncology
  10.2.2. Central Nervous System Disorders
  10.2.3. Cardio Vascular Disorders
  10.2.4. Diabetes
  10.2.5. Infectious Diseases
  10.2.6. Others
10.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Japan
  10.3.2. China
  10.3.3. India
  10.3.4. ASEAN
  10.3.5. Australia & New Zealand
  10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Clinical Research Services Market - Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2017 – 2023
10.5. Asia-Pacific Clinical Research Services Market Dynamics – Trends

11. LATIN AMERICA CLINICAL RESEARCH SERVICES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

11.1. Service Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Treatment Research
  11.1.2. Prevention Research
  11.1.3. Diagnostic Research
  11.1.4. Screening Research
  11.1.5. Quality of LifeResearch
  11.1.6. Genetic studies
  11.1.7. Epidemiological studies
  11.1.8. Clinical Trials
  11.1.9. Others
11.2. Disease Area Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.2.1. Oncology
  11.2.2. Central Nervous System Disorders
  11.2.3. Cardio Vascular Disorders
  11.2.4. Diabetes
  11.2.5. Infectious Diseases
  11.2.6. Others
11.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Brazil
  11.3.2. Mexico
  11.3.3. Argentina
  11.3.4. Venezuela
  11.3.5. Rest of Latin America
11.4. Latin America Clinical Research Services Market - Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2017 – 2023
11.5. Latin America Clinical Research Services Market Dynamics – Trends

12. MIDDLE EAST AND AFRICA CLINICAL RESEARCH SERVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

12.1. Service Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Treatment Research
  12.1.2. Prevention Research
  12.1.3. Diagnostic Research
  12.1.4. Screening Research
  12.1.5. Quality of LifeResearch
  12.1.6. Genetic studies
  12.1.7. Epidemiological studies
  12.1.8. Clinical Trials
  12.1.9. Others
12.2. Disease Area Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.2.1. Oncology
  12.2.2. Central Nervous System Disorders
  12.2.3. Cardio Vascular Disorders
  12.2.4. Diabetes
  12.2.5. Infectious Diseases
  12.2.6. Others
12.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Gulf Cooperation Council (GCC) Countries
  12.3.2. Israel
  12.3.3. South Africa
  12.3.4. Rest of MEA
12.4. MEA Clinical Research Services Market - Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2017 – 2023
12.5. MEA Clinical Research Services Market Dynamics – Trends

13. COMPETITION LANDSCAPE

13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  13.2.1. America Holdings (U.S.)
  13.2.2. IQVIA (U.S.)
  13.2.3. PAREXEL International Corporation (U.S.)
  13.2.4. ICON Plc (Ireland)
  13.2.5. PRA Health Sciences, Inc. (U.S.)
  13.2.6. Wuxi AppTec (Cayman) Inc. (China)
  13.2.7. Pharmaceutical Product Development, LLC (U.S.)
  13.2.8. Charles River Laboratories International Inc. (U.S.)
  13.2.9. Syneos Health

14. RESEARCH METHODOLOGY

15. KEY ASSUMPTIONS AND ACRONYMS